feed,title,long_url,short_url
Benzinga,"Lenograstim Market to Expand at a CAGR of 4.2% during 2023-2031, Says Growth Plus Reports",https://benzinga.com/pressreleases/23/05/g32641394/lenograstim-market-to-expand-at-a-cagr-of-4-2-during-2023-2031-says-growth-plus-reports,
Benzinga,5-Alpha-Reductase Inhibitors (5-ARIs) Market is anticipated to exhibit a CAGR of 4.46% from 2023 to 2031,https://benzinga.com/pressreleases/23/05/g32641384/5-alpha-reductase-inhibitors-5-aris-market-is-anticipated-to-exhibit-a-cagr-of-4-46-from-2023-to-2,
